Preoperative Levels of Uric Acid and Its Association to Some Perioperative Parameters in the Patients with Unstable Angina or Myocardial Infarction |
Kang, Chan-Sik
(Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan)
Seok, Seong-Ja (Department of Clinical Pathology, Sorabol College) Choi, Hwa-Sik (Deptment of Clinical Laboratory Science, Shinheung College) Kim, Dae-Sik (Department of Clinical Laboratory Science, Dongnam Health College) Choi, Seok-Cheol (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) Moon, Seong-Min (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) |
1 | Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Arch Intern Med. 1980. 93: 817-821. DOI ScienceOn |
2 | Morrow DA, Cannon CP, Jesse RL, Newby K, Ravkilde J, Storrow AB, Wu AHB, Christension RH. National academy of clinical biochemistry laboratory medicine practice guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007. 115: e356-e375. DOI |
3 | Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka H, Lakka TA, Salonen JT. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men. Arch Intern Med. 2004. 164: 1546-1551. DOI ScienceOn |
4 | Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk. J Am Coll Cardiol. 2007. 49: 2129-2138. DOI ScienceOn |
5 | Rock-Ramel F, Guisan B, Diezi J. Effects of uricosuric and antiuricosuric agents on urate transport in human brushborder membrane vesicles. J Pharmacol Exp Ther. 1997. 280: 839-845. |
6 | Ryckwaert F, Boccara G, Frappier J, Colson PH. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med. 2002. 30: 1495-1498. DOI ScienceOn |
7 | Schrier RW. Role of diminished renal function in cardiovascular mortality: Marker or pathogenic factor? J Am Coll Cardiol. 2006. 47: 1-8. DOI ScienceOn |
8 | Sim DS, Liew H, Andre P. Biomarkers and bioassays for cardiovascular diseases: Present and future. Biomarker Insights 2008. 3: 293-302. |
9 | Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2006. 47: 51-59. DOI ScienceOn |
10 | Storrow AB, Gibler WB. Chest pain centers: Diagnosis of acute coronary syndromes. Ann Emerg Med. 2000. 35: 449-461. DOI |
11 | Talaat KM, el-Sheikh AR. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol. 2007. 27: 435-440. DOI ScienceOn |
12 | Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol. 2001. 87: 1411-1414. DOI ScienceOn |
13 | Fang J, Alderman MH. Serum uric acid and cardiovascular mortality. JAMA. 2000. 283: 2404-2410. DOI ScienceOn |
14 | Farquharson CA, Butler RH, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002. 106: 221-226. DOI ScienceOn |
15 | Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008. 359: 1811-1821. DOI ScienceOn |
16 | Ford ES, Cook CLIS, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007. 115: 2526-2532. DOI ScienceOn |
17 | Galvan AQ, A Natali, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E. Effect of insulin on uric acid excretion in humans. Am J Physiol. 1995. 268: E1-E5. |
18 | Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve Clin J Med. 2006. 73: 1059-1064. DOI ScienceOn |
19 | Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: Insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 2003. 107: 1951-1953. DOI ScienceOn |
20 | Haverkate F, Thompson FG, Pyke SDM. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997. 349: 462-466. DOI ScienceOn |
21 | Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003. 41: 1183-1190. DOI ScienceOn |
22 | Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Ann Intern Med. 1986. 105: 221-233. DOI ScienceOn |
23 | Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulindependent diabetes mellitus. Stroke 1998. 29: 635-639. DOI ScienceOn |
24 | Leyva F, Anker S, Godsland JW, Wingrove CS, Chua TP, Stevenson JC, Coats AJ. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J. 1997. 8: 858-865. |
25 | Many A, Hubel CQA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revited. Am J Obstet Gynecol. 1996. 174: 288-291. DOI |
26 | Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Hetzer R, Ponikowski P, Coats AJS. Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003. 107: 1991-1997. DOI ScienceOn |
27 | Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? Am J Med. 2005. 118: 86-826. |
28 | Baillie K, Bates M, Thompson R, Waring S, Partridge R, Simpson A, Maxwell S. Endogenous urate production augments plasma antioxidants capacity in healthy lowland subjects exposed to high altitude. Chest 2007. 131: 1473-1478. DOI ScienceOn |
29 | Braunwald E. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2000. 36: 970-1062. DOI ScienceOn |
30 | Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Breteler MMB. Uric acid is a risk factor for myocardial infarction and stroke: The Rotterdam study. Stroke 2006. 37: 1503-1507. DOI ScienceOn |
31 | Brown TM, Bittner V. Biomarkers of atherosclerosis: Clinical applications. Curr Cardiol Rep. 2008. 10: 497-504. DOI ScienceOn |
32 | Butler R, Morris AD, Belch JJF, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetes with mild hypertension. Hypertension 2000. 35: 746-751. DOI ScienceOn |
33 | Cannon PJ, Stason WB, Demartini FE, Sommers SC, Laragh JH. Hyperuricemia in primary and renal hypertension. N Engl J Med. 1966. 275: 457-464. DOI ScienceOn |
34 | Dawson J, Walters M. Uric acid and xanthine oxidase: Future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol. 2006. 62: 633-644. DOI ScienceOn |
35 | de Lemos JA, Morrow DA. Brain natriuretic peptide measurement in acute coronary syndromes: Ready for clinical application? Circulation 2002. 106: 2868-2870. DOI ScienceOn |
36 | de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003. 362: 316-322. DOI ScienceOn |
37 | Doehner W, Schoene N, Leyva-Leon F, Pavit DV, Reaveley DA, Schuler G, Coats AJS, Anker SD, Hambrecht R. Effects of xanthine oxidase inhibition with alloputinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure. Circulation 2002. 105: 2619-2624. DOI ScienceOn |
38 | Anderson RJ, O'Brien M, MaWhinney S, VillaNueva CB, Moritz TE, Sethi GK, Henderson WG, Hanmermeister KE, Grover FL, Shroyer AL. Renal failure predisposes patients to adverse outcome after coronary artery bypass surgery. Kidney Int. 1999. 55: 1057-1062. DOI ScienceOn |
39 | Achar SA, Kundu S, Norcross WA. Diagnosis of acute coronary syndrome. Am Fam Physician 2005. 72: 119-126. |
40 | Alberto P, Francesca I, Chiara S, Ranuccio N. Acute coronary syndromes: From the laboratory markers to the coronary vessels. Biomarker Insights 2006. 1: 123-130. |